LEGN
Legend Biotech Corp
NASDAQ: LEGN · HEALTHCARE · BIOTECHNOLOGY
$22.77
-3.35% today
Updated 2026-04-29
Market cap
$4.21B
P/E ratio
—
P/S ratio
4.09x
EPS (TTM)
$-1.62
Dividend yield
—
52W range
$16 – $45
Volume
1.9M
Legend Biotech Corp (LEGN) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-28.80%
Operating margin
-6.72%
ROE
-29.10%
ROA
-5.01%
Debt/equity
0.41x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2017 | $23.59M | $9.37M | 100.41% | 58.41% | 39.69% |
| 2018 | $49.13M | $-2.78M | 100.00% | -3.12% | -5.67% |
| 2019 | $61.80M | $-101.59M | 100.00% | -214.42% | -164.39% |
| 2020 | $75.00M | $-266.37M | 100.00% | -417.79% | -355.16% |
| 2021 | $68.83M | $-403.58M | 100.00% | -569.97% | -586.38% |
| 2022 | $117.00M | $-446.35M | 44.14% | -389.40% | -381.48% |
| 2023 | $285.14M | $-518.25M | 49.42% | -154.13% | -181.75% |
| 2024 | $627.24M | $-177.03M | 62.60% | -48.35% | -28.22% |
| 2025 | $1.03B | $-297.58M | 60.34% | -13.27% | -28.85% |